Literature DB >> 32759328

Arm-only access for combined transarterial and transvenous neurointerventional procedures.

Jorge Galvan Fernandez1, Mario Martínez-Galdámez2, Miguel Schüller Arteaga1, Joaquín Ortega-Quintanilla3, Antonio Hermosín4, Eduardo Crespo-Vallejo4, Carlos A Rodriguez-Arias5.   

Abstract

A simultaneous arterial and venous approach has been widely described for the endovascular treatment of dural arteriovenous fistula (DAVFs) and recently for arteriovenous malformation (AVMs). Conventional venous approaches are performed by direct internal jugular puncture or by femoral access. Although complication rates are low, there are potential life-threatening complications that should be avoided. The advantages of radial artery access have been widely proven, nevertheless the use of upper limb veins in neurointervention are rarely reported. We present five cases of the simultaneous arteriovenous approach through the radial artery and superficial veins of the forearm for the treatment of intracranial neurovascular diseases. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  arteriovenous malformation; hemorrhage; technique

Year:  2020        PMID: 32759328     DOI: 10.1136/neurintsurg-2020-016540

Source DB:  PubMed          Journal:  J Neurointerv Surg        ISSN: 1759-8478            Impact factor:   5.836


  2 in total

1.  #RadialFirst and #RadialForNeuro: A descriptive analysis of Twitter conversations regarding transradial access.

Authors:  Faith C Robertson; Joseph R Linzey; Naif M Alotaibi; Robert W Regenhardt; Pablo Harker; Justin Vranic; Adam A Dmytriw; Matthew J Koch; Christopher J Stapleton; Thabele M Leslie-Mazwi; Aman B Patel
Journal:  Neuroradiol J       Date:  2021-04-30

2.  Endovascular Treatment of Cavernous Sinus Dural Arteriovenous Fistula via Radial Artery and Median Cubital Vein.

Authors:  Wen Nian Tan; Arvin Rajadurai; Dhayal Balakrishnan
Journal:  Neurointervention       Date:  2021-06-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.